Study Suggests Adults With Pathogenic CHD2 Variants Continue To Have Seizures, Severe Comorbidities

Neurology Advisor (1/31, Nye) reported “adults with pathogenic chromodomain helicase DNA binding protein 2 (CHD2) variants continue to have seizures and severe comorbidities, according” to study findings. Researchers found that “worse seizure severity was related to worse nonseizure outcomes.” The findings were published in Neurology Genetics.